Skip to main content
. 2021 Jan 20;11:601639. doi: 10.3389/fimmu.2020.601639

Figure 3.

Figure 3

Characterization of cells expressing CXCL16 and CX3CL1 in proliferative diabetic retinopathy epiretinal fibrovascular membranes. Immunohistochemical staining for CXCL16 (A) and CX3CL1 (C) showing immunoreactivity in vascular endothelial cells (arrows). Immunoreactivity for CXCL16 was also detected in stromal spindle-shaped cells (arrows) (B). Double immunohistochemistry for CD45 (brown) and CXCL16 (red) (D) or CX3CL1 (red) (E) demonstrated co-expression in stromal leukocytes (arrows). No counterstain was applied in panels (D, E) (scale bar, 10 μm).